Skip to main content
logo
Beijing SL Pharmaceutical Co., Ltd. (SHE:002038)
China flag China · Delayed Price · Currency is CNY
6.75
-0.08 (-1.17%)
Apr 29, 2026, 3:04 PM CST

Beijing SL Pharmaceutical Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Market Capitalization
7,0177,5727,67410,4698,44511,106
Market Cap Growth
-0.44%-1.34%-26.69%23.97%-23.96%7.03%
Enterprise Value
6,0716,6266,7629,6077,40410,195
Last Close Price
6.837.377.459.967.9510.35
PE Ratio
---25.1236.0326.07
Forward PE
-12.3512.3512.3512.3512.35
PS Ratio
11.2512.1411.6210.288.049.14
PB Ratio
1.351.461.381.801.542.09
P/TBV Ratio
1.541.671.572.051.712.30
P/FCF Ratio
108.47117.04-43.2937.3148.77
P/OCF Ratio
27.2329.3934.0322.7521.6623.90
PEG Ratio
-1.771.771.771.771.77
EV/Sales Ratio
9.7310.6210.249.437.058.39
EV/EBITDA Ratio
36.9940.3737.4426.2828.7932.68
EV/EBIT Ratio
--244.5843.6551.5448.02
EV/FCF Ratio
93.84102.42-39.7232.7144.77
Debt / EBITDA Ratio
-----0.01
Debt / FCF Ratio
-----0.01
Net Debt / Equity Ratio
-0.20-0.20-0.35-0.37-0.26-0.31
Net Debt / EBITDA Ratio
-6.20-6.20-10.98-5.84-5.65-5.24
Net Debt / FCF Ratio
-15.74-15.7416.26-8.82-6.42-7.17
Asset Turnover
0.100.100.110.170.180.22
Inventory Turnover
0.510.511.091.341.201.55
Quick Ratio
1.531.537.276.356.026.20
Current Ratio
2.872.878.607.076.927.07
Return on Equity (ROE)
-6.47%-6.47%-1.32%7.35%4.23%8.17%
Return on Assets (ROA)
-0.03%-0.03%0.28%2.26%1.54%2.38%
Return on Invested Capital (ROIC)
-0.06%-0.07%0.76%5.10%3.28%5.40%
Return on Capital Employed (ROCE)
0.00%0.00%0.50%3.70%2.60%3.90%
Earnings Yield
-4.95%-4.59%-0.97%3.98%2.78%3.84%
FCF Yield
0.92%0.85%-1.59%2.31%2.68%2.05%
Dividend Yield
0.29%-0.27%1.51%1.26%0.97%
Payout Ratio
---24.65%43.83%24.17%
Buyback Yield / Dilution
3.49%3.49%-4.11%0.28%1.90%-2.55%
Total Shareholder Return
3.78%3.49%-3.84%1.78%3.16%-1.58%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.